RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2000; 84(05): 919-920
DOI: 10.1055/s-0037-1614139
DOI: 10.1055/s-0037-1614139
Letters to the Editor
The Role of the Thiol Group in the Antithrombotic Action of Captopril
This work was supported by Grant No. 4 PO5A 085 10 from the State Committee for Scientific Research, Poland. The authors are grateful to Bristol-Myers Squibb (Poland and USA) for the supply of epicaptopril. The authors thank Aneta Buslowska for excellent technical assistance.
Weitere Informationen
Publikationsverlauf
Received
28. Februar 2000
Accepted after rivision
31. Mai 2000
Publikationsdatum:
13. Dezember 2017 (online)
-
References
- 1 Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 1993; 87: 1969-73.
- 2 Pawlak R, Chabielska E, Golatowski J, Azzadin A, Buczko W. Nitric oxide and prostacyclin are involved in antithrombotic activity of captopril in venous thrombosis in rats. Thromb Haemost 1998; 79: 1208-12.
- 3 Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89: 7674-7.
- 4 Lidbury PS, Korbut R, Vane JR. Sodium nitropruside modulates the fibrinolytic system in the rabbit. Br J Pharmacol 1990; 101: 527-30.